Mengenal Jenis-jenis Terapi Kanker Payudara (Terapi Hormonal dan Terapi Target)

Summary

This video offers an insightful overview of breast cancer therapy, focusing on treatments like hormonal therapy, targeted therapy, and systemic therapy. It explains how systemic therapy can shrink tumors before surgery or prevent recurrence after surgery, while hormonal and targeted therapies are aimed at blocking cancer cell growth. The video also discusses different drug options, including chemotherapy, aromatase inhibitors, and trastuzumab for Herto-positive cancer. It emphasizes the importance of communication with doctors, understanding side effects, and staying engaged in one's treatment journey, urging viewers to participate in regular screenings for early detection and better outcomes.

Takeaways

• 😀 Early detection of breast cancer is crucial for higher life expectancy.
• 😀 Hormonal therapy and targeted therapy are common treatment options for breast cancer.
• 😀 Systemic therapy can be given before or after surgery to reduce tumor size or prevent recurrence.
• 😀 Hormonal therapy blocks estrogen receptors or reduces estrogen production to treat hormone-sensitive breast cancers.
• 😀 For pre-menopausal patients, hormonal therapy may include drugs like gnrh agonists or aromatase inhibitors.
• 😀 After menopause, hormonal therapy aims to stop estrogen production from body fat or block its effects on breast cancer tissue.
• 😀 Targeted therapy is used for HER2-positive breast cancer and works by blocking the HER2 receptor, which causes rapid cancer cell division.
• 😀 Trastuzumab, pertuzumab, and lapatinib are examples of drugs used in targeted therapy for HER2-positive breast cancer.
• 😀 Side effects of therapies, including hormonal and targeted therapies, should be discussed with the doctor to monitor and manage them effectively.
• 😀 Communication with the doctor about treatment options, side effects, and personal concerns is essential for a smooth cancer treatment journey.

Q & A

What are the main types of breast cancer therapy mentioned in the video?

The main types of breast cancer therapy mentioned are hormonal therapy, targeted therapy, and systemic therapy, including chemotherapy, hormonal therapy, and immunotherapy.

How does systemic therapy work in the early and advanced stages of breast cancer?

In the early stages, systemic therapy can be given before or after surgery to reduce the tumor size, prevent distant spread, and lower the risk of recurrence. In advanced stages, systemic therapy is the primary form of treatment.

What are the two main classes of drugs used in hormonal therapy?

The two main classes of drugs used in hormonal therapy are GnRH agonists (e.g., leuproline, goserelin), which suppress estrogen production from the ovaries, and aromatase inhibitors (e.g., letrozole, anastrozole, exemestane), which suppress estrogen production from body fat.

What is the purpose of hormonal therapy in breast cancer treatment?

Hormonal therapy aims to block estrogen receptors or reduce the production of estrogen, which can fuel the growth of certain types of breast cancer.

What is the difference between the hormonal therapy prescribed for premenopausal and postmenopausal women?

For premenopausal women, hormonal therapy may include drugs that inhibit estrogen production in the ovaries or suppress ovarian function. For postmenopausal women, the therapy usually involves drugs that inhibit estrogen production from fat tissue or block estrogen effects on breast cancer cells.

What are the side effects of hormonal therapy and how should patients manage them?

Side effects from hormonal therapy can vary, depending on the treatment. Patients should consult their doctor to understand potential side effects and report any symptoms immediately to manage them effectively.

What is targeted therapy, and how does it work for HER2-positive breast cancer?

Targeted therapy is used for HER2-positive breast cancer, a type that grows aggressively. It works by blocking the HER2 receptor, which helps cancer cells divide quickly. Drugs such as trastuzumab and pertuzumab are commonly used in this therapy.

How long should targeted therapy be administered for HER2-positive breast cancer?

Research suggests that targeted therapy with anti-HER2 treatment should be given for one year to achieve optimal results and reduce the risk of recurrence, both in early and advanced stages of HER2-positive breast cancer.

Can systemic therapy be given before surgery in breast cancer patients who want to preserve their breasts?

Yes, systemic therapy can be given before surgery in certain cases, such as for patients with larger tumors or positive lymph nodes, to reduce the tumor size and enable breast preservation.

What should patients discuss with their doctor regarding breast cancer treatment?

Patients should actively communicate with their doctor to discuss their diagnosis, treatment options, side effects, expectations, and concerns regarding fertility, quality of life, and personal goals. It's essential to ensure that the treatment plan aligns with their needs.